SOLAXA
Live / Applied — Fifth extension granted (statement of use) (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 16 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97314635
- Mark type
- Stylized text
- Filed
- 16 Mar 2022
- Published for opposition
- 31 Jan 2023
- Attorney of record
- Randy Michels
Goods and services
- Class 005 — Pharmaceuticals: Neuro-regenerative pharmaceutical products for the treatment of nerve injuries
Owner
- Solaxa Inc., Chevy Chase, MD, US
- Solaxa Inc., Chevy Chase, MD, US
Prosecution history
- 13 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 5 GRANTED
- 25 Sept 2025 — SOU EXTENSION 5 FILED
- 11 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2025 — SOU EXTENSION 4 GRANTED
- 05 Feb 2025 — SOU EXTENSION 4 FILED
- 05 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2024 — SOU EXTENSION 3 GRANTED
- 31 Jul 2024 — SOU EXTENSION 3 FILED
- 31 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2024 — SOU EXTENSION 2 GRANTED